Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission
Top Cited Papers
- 10 July 2008
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 359 (2), 119-129
- https://doi.org/10.1056/nejmoa0801941
Abstract
Effective strategies are urgently needed to reduce mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding in resource-limited settings.Keywords
This publication has 14 references indexed in Scilit:
- Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating infants or mothers prophylactically with antiretrovirals in Dar es Salaam, Tanzania: the MITRA and MITRA PLUS studiesRetrovirology, 2008
- Balancing Maternal and Infant Benefits and the Consequences of Breast‐Feeding in the Developing World during the Era of HIV InfectionThe Journal of Infectious Diseases, 2007
- CD4+ Count–Guided Interruption of Antiretroviral TreatmentNew England Journal of Medicine, 2006
- A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothersAIDS, 2005
- Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African SettingJAMA, 2004
- Breast-feeding and Transmission of HIV-1JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trialThe Lancet, 2003
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West AfricaAIDS, 2002
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999